SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-688706
Filing Date
2016-08-23
Accepted
2016-08-23 16:06:55
Documents
5
Period of Report
2016-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d245713d8k.htm 8-K 17800
2 EX-1.1 d245713dex11.htm EX-1.1 165159
3 EX-5.1 d245713dex51.htm EX-5.1 11574
4 GRAPHIC g245713g18h58.jpg GRAPHIC 2480
5 GRAPHIC g245713g51p86.jpg GRAPHIC 3781
  Complete submission text file 0001193125-16-688706.txt   204555
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35993 | Film No.: 161847323
SIC: 2834 Pharmaceutical Preparations